Background Randomized controlled trials have shown the importance of tight glucose
control in type 1 diabetes (T1DM), but few recent studies have evaluated the risk of …

Background Both type 1 and type 2 diabetes are well-established risk factors for
cardiovascular disease and early mortality. However, few studies have directly compared …

OBJECTIVE We evaluated whether cardiometabolic risk profiles differ for subjects identified
as having prediabetes by A1C, fasting glucose (FPG), or 2-h postchallenge glucose (2-PG) …

OBJECTIVE—We compared and contrasted cardiovascular disease (CVD) risk factors,
subclinical manifestations of CVD, incident coronary heart disease (CHD), and all-cause …

Importance Prediabetes, an intermediate stage between normal glucose regulation and
diabetes, affects 1 in 3 adults in the US and approximately 720 million individuals …

OBJECTIVE—Diabetes has been defined as a coronary heart disease (CHD) risk
equivalent, and more aggressive treatment goals have been proposed for diabetic patients …

Previously diagnosed diabetes mellitus, newly diagnosed diabetes mellitus, and impaired
glucose tolerance are important determinants of the risk of clinical cardiovascular disease …

Aim To investigate multiple risk factor target attainment in adults with diabetes mellitus (DM)
for atherosclerotic cardiovascular disease (ASCVD) prevention and the predictors of such …

Objectives: We sought to determine whether impaired fasting glucose (IFG) predicts
cardiovascular disease (CVD) events. Background: It is unclear which glucose threshold …

Background The severity of the metabolic syndrome (MetS) is significantly associated with
future coronary heart disease (CHD) among individuals without baseline Type 2 diabetes …